Alfasigma S.p.a.

This study looks at the long-term safety and effectiveness of the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA). Participants must have already completed a previous filgotinib study and shown improvement. The goal is to see if the drug continue…

This study tests an oral drug called filgotinib in about 80 children aged 8 to 18 with moderate-to-severe ulcerative colitis, a chronic bowel disease. The goal is to see if the drug can reduce inflammation and control symptoms like diarrhea and bleeding. All participants receive …

This study is testing an oral medication called filgotinib in 10 children and teens aged 8 to 17 who have juvenile idiopathic arthritis (JIA). The goal is to see how the drug moves through the body and whether it is safe and tolerable. Participants must have moderately to severel…